We are live on ! Find out more

1,619 hedge funds and large institutions have $126B invested in Merck in 2014 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 602 increasing their positions, 699 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 53

5% more funds holding in top 10

Funds holding in top 10: 140147 (+7)

0% more call options, than puts

Call options by funds: $950M | Put options by funds: $950M

0% less funds holding

Funds holding: 1,6211,619 (-2)

1% less capital invested

Capital invested by funds: $127B → $126B (-$978M)

1.04% less ownership

Funds ownership: 78.25%77.21% (-1%)

14% less repeat investments, than reductions

Existing positions increased: 602 | Existing positions reduced: 699

Holders
1,619
Holders Change
-2
Holders Change %
-0.12%
% of All Funds
46.95%
Holding in Top 10
147
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+5%
% of All Funds
4.26%
New
65
Increased
602
Reduced
699
Closed
53
Calls
$950M
Puts
$950M
Net Calls
+$352K
Net Calls Change
-$100M
Name Holding Trade Value Shares
Change
Change in
Stake
Capital World Investors
1
Capital World Investors
California
$10.4B -$1.13M -20,168 -0%
Vanguard Group
2
Vanguard Group
Pennsylvania
$9.08B +$154M +2,743,901 +2%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$8.89B -$149M -2,656,430 -2%
State Street
4
State Street
Massachusetts
$7.48B +$107M +1,905,769 +1%
BIT
5
BlackRock Institutional Trust
California
$4.53B -$40.4M -719,486 -0.9%
Franklin Resources
6
Franklin Resources
California
$3.9B -$491M -8,750,375 -11%
Bank of New York Mellon
7
Bank of New York Mellon
New York
$3.35B +$12.7M +226,169 +0.4%
JP Morgan Chase
8
JP Morgan Chase
New York
$2.58B +$434M +7,731,329 +20%
Northern Trust
9
Northern Trust
Illinois
$2.54B -$56.2M -1,001,008 -2%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$2.5B -$197M -3,510,088 -7%
BFA
11
BlackRock Fund Advisors
California
$2.35B +$58.7M +1,045,761 +3%
Dodge & Cox
12
Dodge & Cox
California
$2.08B -$53.1M -945,788 -3%
Fidelity Investments
13
Fidelity Investments
Massachusetts
$2.01B -$869M -15,476,246 -30%
Deutsche Bank
14
Deutsche Bank
Germany
$1.7B +$85.1M +1,515,876 +5%
Invesco
15
Invesco
Georgia
$1.48B -$14.8M -264,212 -1%
BG
16
BlackRock Group
United Kingdom
$1.44B -$87.7M -1,561,156 -6%
Ameriprise
17
Ameriprise
Minnesota
$1.43B +$159M +2,832,890 +13%
Barrow, Hanley, Mewhinney & Strauss
18
Barrow, Hanley, Mewhinney & Strauss
Texas
$1.35B -$1.42M -25,277 -0.1%
Norges Bank
19
Norges Bank
Norway
$1.31B -$1.3B -23,235,538 -50%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$1.29B -$17.7M -315,392 -1%
Jennison Associates
21
Jennison Associates
New York
$1.17B -$12.6M -224,244 -1%
Bank of America
22
Bank of America
North Carolina
$1.07B -$5.98M -106,536 -0.6%
BA
23
BlackRock Advisors
Delaware
$1.07B -$95M -1,690,940 -8%
TCIM
24
TIAA CREF Investment Management
New York
$898M -$76.8M -1,367,116 -8%
State Farm Mutual Automobile Insurance
25
State Farm Mutual Automobile Insurance
Illinois
$898M

MRK Hedge Fund Activity: Q3 2014 in Review

1,619 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2014, worth a combined $126B — down 0.77% from $127B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new MRK positions and 53 closed out — a net gain of 12 holders — while 602 added to existing stakes and 699 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $434M. The largest seller was Norges Bank, cutting an estimated $1.3B.

  • 1,619 institutional investors held Merck (MRK) as of Q3 2014, down from 1,621 in Q2 2014.
  • Funds reported $126B of Merck stock for Q3 2014, down 0.77% quarter-over-quarter.
  • 65 funds opened new Merck positions in Q3 2014 and 53 closed out, a net change of +12 holders.
  • The largest Merck buyer in Q3 2014 was JP Morgan Chase, an estimated $434M added.
  • The largest Merck seller in Q3 2014 was Norges Bank, an estimated $1.3B sold.

Based on aggregated 13F filings for Q3 2014.